EUVIMEDEUVIMED entdecken
Crossref

Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1

Wenjing Xiang, Yang Yang, Liangkun Weng, Zhiming Ye, Ping Ding, Huayu Li, Jia Sun, Cheng Zeng

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Wenjing Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance, Hyperhomocysteinemia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Guangdong Provincial Medical Research Foundation, Guangzhou Municipal Science and Technology Project, Guangzhou Science Technology and Innovation Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperhomocysteinemia (HHcy) is associated with nonalcoholic fatty liver disease (NAFLD) and insulin resistance (IR). However, the underlying mechanism is still unknown. Recent studies have demonstrated that NLRP3 inflammasome activation plays a vital role in NAFLD and IR. Our study aimed to explore whether NLRP3 inflammasome contributed to HHcy-induced NAFLD and IR as well as dissected the underlying mechanism. C57BL/6 mice were fed a high-methionine diet (HMD) for 8 weeks to establish the HHcy mouse model. Compared with a chow diet, HMD induced hepatic steatosis (HS) and IR as well as activation of hepatic NLRP3 inflammasome. Moreover, HHcy-induced NAFLD and IR characterization disclosed that NLRP3 inflammasome activation occurred in liver tissue of HMD-fed mice, but was very marginal in either NLRP3-/- or Caspase-1-/- mice. Mechanistically, high levels of homocysteine (Hcy) up-regulated the expression of mouse double minute 2 homolog (MDM2), which directly ubiquitinates heat shock transcription factor 1 (HSF1) and consequently activated hepatic NLRP3 inflammasome in vivo and in vitro. In addition, in vitro experiments showed P300-mediated HSF1 acetylation at K298 hindered MDM2-mediated ubiquitination of HSF1 at K372, which plays important role in determining the HSF1 level. Importantly, either inhibition of MDM2 by JNJ-165 or activation of HSF1 by HSF1A reversed HMD-induced hepatic NLRP3 inflammasome, and consequently alleviated HS and IR in mice. This study demonstrates that NLRP3 inflammasome activation contributes to HHcy-induced NAFLD and IR, and further identified that HSF1 as a new substrate of MDM2 and its decrease on MDM2-mediated ubiquitination at K372 modulates NLRP3 inflammasome activation. These findings may provide novel therapeutic strategies aimed at halting HS or IR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseInsulin ResistanceHyperhomocysteinemiaMiceAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinHeat Shock Transcription FactorsMice, Inbred C57BLLiverMethionineUbiquitination

Stichwörter der Autor:innen

HSF1HyperhomocysteinemiaInsulin resistanceMDM2NLRP3 inflammasomeNonalcoholic fatty liver disease

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinHeat Shock Transcription FactorsMethionineHsf1 protein, mouseNlrp3 protein, mouse

Autor:innen und Institutionen

  • School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Department of Pharmacy, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, 519000, China.
  • Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, 510699, C…

Förderung

  • Guangdong Provincial Medical Research Foundation
  • Guangzhou Municipal Science and Technology Project
  • Guangzhou Science Technology and Innovation Commission
  • National Clinical Key Specialty Project Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Xiang, W., Yang, Y., Weng, L., Ye, Z., Ding, P., Li, H., Sun, J., & Zeng, C. (2023). Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110085

Vancouver

Xiang W, Yang Y, Weng L, Ye Z, Ding P, Li H, et al. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110085

BibTeX
@article{Xiang2023,
  author = {Xiang, Wenjing and Yang, Yang and Weng, Liangkun and Ye, Zhiming and Ding, Ping and Li, Huayu and Sun, Jia and Zeng, Cheng},
  title = {Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110085}
}
Kostenlos starten →